Physician profile
Gerald Gordon
NPI 1396738753
$12,572.77
in general payments reported to CMS, 2019-2025
68 companies · $684 in 2025
The $684 reported for 2025 was more than what 79% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,230 · 2020: $1,773 · 2021: $2,253 · 2022: $2,175 · 2023: $1,878 · 2024: $1,580 · 2025: $684.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,141.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,141.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,594.91 | 2019-2025 | Breztri, Farxiga, Airsupra |
| Insmed, INC. | $938.30 | 2019-2025 | Arikayce, Brinsupri |
| Lilly USA, LLC | $880.45 | 2019-2024 | Mounjaro |
| Novo Nordisk INC | $805.85 | 2019-2024 | Ozempic, Wegovy, Rybelsus |
| Novartis Pharmaceuticals Corporation | $757.12 | 2019-2025 | |
| Abbvie INC. | $635.55 | 2021-2024 | |
| Gilead Sciences, INC. | $434.57 | 2019-2023 | Biktarvy |
| Glaxosmithkline, LLC. | $370.25 | 2020-2024 | Trelegy Ellipta, Shingrix, Arexvy |
| Organogenesis INC. | $355.49 | 2022-2024 | Puraply, Puraply Wound Matrix |
| Amgen INC. | $349.01 | 2019-2024 | Prolia, Evenity, Otezla |
| Merck Sharp & Dohme LLC | $328.87 | 2019-2025 | Verquvo, Dificid, Belsomra |
| Melinta Therapeutics, LLC | $326.91 | 2021-2023 | Rezzayo, Vabomere, Kimyrsa |
| Allergan, INC. | $309.01 | 2019-2020 | |
| Corcept Therapeutics | $292.37 | 2019-2025 | Korlym |
| Pfizer INC. | $271.56 | 2020-2025 |
Show all 68 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $228.10 | 2019-2024 | Jardiance |
| Sanofi-Aventis U.S. LLC | $214.88 | 2019-2021 | |
| Astellas Pharma US INC | $202.33 | 2019-2023 | Veozah |
| Bayer Healthcare Pharmaceuticals INC. | $201.14 | 2022-2024 | |
| Viiv Healthcare Company | $200.77 | 2019-2022 | |
| Inari Medical, INC. | $189.02 | 2022-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Insulet Corporation | $164.89 | 2019-2023 | Omnipod |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $153.26 | 2020-2024 | Xifaxan, Trulance |
| Takeda Pharmaceuticals U.S.A., INC. | $147.49 | 2019-2023 | Trintellix |
| Kerecis Limited | $137.33 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Paratek Pharmaceuticals, INC. | $132.78 | 2020-2022 | |
| Amarin Pharma, INC. | $125.47 | 2020-2021 | |
| Zealand Pharma US, INC. | $121.08 | 2021-2022 | |
| Mannkind Corporation | $114.47 | 2019-2021 | |
| Vbi Vaccine (Delaware) INC. | $106.20 | 2022-2023 | Prehevbrio |
| Abbott Laboratories | $102.71 | 2021-2024 | Freestyle Libre 3 |
| Xeris Pharmaceuticals, INC. | $102.00 | 2021-2023 | Gvoke Hypopen |
| Dexcom, INC. | $100.31 | 2020-2023 | Dexcom G6 Transmitter |
| Cequr Corporation | $87.67 | 2023-2024 | Cequr Simplicity |
| Janssen Pharmaceuticals, INC | $76.35 | 2020-2021 | |
| Exact Sciences Corporation | $72.63 | 2023-2024 | Cologuard Collection Kit |
| Arbor Pharmaceuticals, INC. | $69.89 | 2020-2022 | |
| Daiichi Sankyo INC. | $66.98 | 2022-2025 | Injectafer |
| Shionogi INC | $65.10 | 2025 | Fetroja |
| Beta Bionics, INC. | $64.14 | 2024-2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Contact Detach, Ilet Insulin Infusion Kit Inset |
| Theratechnologies INC. | $59.15 | 2019-2020 | |
| Lundbeck LLC | $53.89 | 2020-2024 | Rexulti |
| Radius Health, INC. | $46.76 | 2020-2021 | |
| Ferring Pharmaceuticals INC. | $41.29 | 2023-2025 | Rebyota |
| Boston Scientific Corporation | $40.50 | 2021-2024 | Watchman Flx |
| Hydrofera LLC | $28.06 | 2023 | Hydrofera Blue |
| Mylan Specialty L.P. | $28.02 | 2020-2022 | |
| Otsuka America Pharmaceutical, INC. | $27.98 | 2024 | Rexulti |
| Grifols USA, LLC | $26.82 | 2025 | Xembify |
| Eisai INC. | $26.14 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $26.00 | 2021 | |
| Stryker Corporation | $21.19 | 2025 | Flowtriever |
| Vyera Pharmaceuticals, LLC | $20.94 | 2019 | |
| Cvrx, INC. | $19.48 | 2024 | Barostim Neo System |
| Aimmune Therapeutics, INC. | $18.38 | 2024 | |
| Si-Bone, INC. | $17.47 | 2019 | |
| La Jolla Pharmaceutical Company | $17.35 | 2021 | |
| Tetraphase Pharmaceuticals, INC. | $16.97 | 2019 | |
| Esperion Therapeutics, INC. | $16.28 | 2024 | Nexletol |
| Medtronic Minimed, INC. | $15.94 | 2020 | |
| Biohaven Pharmaceuticals, INC. | $15.36 | 2021 | |
| Genzyme Corporation | $14.09 | 2019 | |
| Seqirus USA INC | $14.01 | 2021 | |
| Medtronic, INC. | $13.49 | 2021 | |
| Janssen Biotech, INC. | $12.92 | 2022 | |
| Philips North America LLC | $12.82 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $12.40 | 2021 | |
| Currax Pharmaceuticals LLC | $11.86 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gerald Gordon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.